Work

OA18.02 Evaluation of a Modified Dosing Regimen (2-Weeks on/1-Week off) of Sunitinib as Part of a Phase II Trial in Thymic Carcinoma

Year: 2017

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2016.11.332

Authors: Arun Rajan, Chul Kim, Udayan Guha, Eva Szabo, Arlene Berman, Linda Sciuto, A. John Spittler, Jane Trepel, Seth Steinberg, Pamela Harris, Raffit Hassan, Patrick Loehrer

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Indiana University

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2569985296

Cites:

Cited by: 7

Related to: 10